Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NivoMet: Nivolumab + Metformin in mRCC
NCT06884683Phase 2Terminated
- Sponsor
- Policlinico Gemelli
- Start
- Sep 2020
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in metastatic renal cell carcinoma (mRCC), sponsored by Policlinico Gemelli. Started Sep 2020; status: terminated.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
metastatic renal cell carcinoma (mRCC)
Beyond the preview
Go deeper on NCT06884683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06884683.